We are monitoring the impact of COVID-19 on APAC BCG Vaccine Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific BCG Vaccine Market Research Report - Segmented By Demographics, Product Type, Application & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 5022
Pages: 145

Asia Pacific BCG Vaccine Market Size & Growth (2022 to 2027):

As per the research report, the Asia Pacific BCG Vaccine Market size was valued at USD 10.44 billion in 2022 and is expected to grow at a CAGR of 7 %, to reach USD 14.65 billion by 2027 from 2022 to 2027. 

The Increasing number of Tuberculosis cases, surging BCG immunization coverage, and technological advancements in vaccine development are driving the BCG vaccine market growth. Also, the change of TB in the adult stage of society is likely to boost demand throughout the forecast period. 

The growing senior population in emerging countries such as China and India significantly increases the demand for the BCG vaccines daily. 

Other factors such as improving healthcare infrastructure, high healthcare spending, and favorable government policies in the region boost market growth. 

However, the growing disease outbreaks influence supply and demand dynamics and may determine increased demand for BCG vaccination and the future evolution of the BCG vaccine pipeline.

The Initiatives taken by the government for creating awareness among the people about the BCG vaccines and immunization programs are most likely to accelerate the market growth. 

Furthermore, the BCG vaccine market is developing significantly in the region because the key companies are focusing upon the regional market's growth by implanting various market strategies. The strategies include partnerships, mergers, and acquisitions. 

However, problems such as the BCG vaccine's adverse effects, such as swollen glands and headaches, are projected to limit market growth throughout the projection period.

In addition, demand inflexibility poses a problem to the sector; the emerging countries in the region are also experiencing supply issues. The government's minimal investment in vaccine manufacture impacts availability and output. Furthermore, unpleasant vaccination side effects and global supply constraints are projected to hamper market expansion throughout the projection period.

This research report on the Asia Pacific BCG Vaccine Market has been segmented and sub-segmented into the following categories.

By Demographics:

  • Pediatrics (0-18 years)
  • Adults (19-35 years)

By Product Type:

  • BCG Vaccine 
  • Immune BCG
  • Therapy BCG          

By End User:

  • Pediatrics
  • Adults       

By Applications:

  • Home
  • Commercial            

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia Pacific is estimated to increase at the fastest rate and witness significant growth during the forecast period. As a result, the APAC is the second most attractive market for BCG vaccinations; TB incidence is higher in this region due to significant countries like India, Japan, and Malaysia, which account for about 40% of the world's TB population. As a result, the BCG vaccination market in this region. Moreover, the government across the region is initiating awareness programs. 

The China's BCG vaccine market recorded the majority share of the BCG vaccines market, and it is anticipated to register a significant share during the forecast period. The high prevalence of tuberculosis, such as TB eradication programs in emerging nations, is expected to influence market growth positively. In addition, well-established healthcare infrastructure, pharmaceutical research and developments, and supportive government vaccination programs are uplifting the market growth. 

The Indian BCG vaccine market and Japan BCG vaccine market are projected to showcase a considerable share in the market during the forecast period. In addition, a growing emphasis on newborn immunization for protection against severe or deadly infections like TB and rising occurrences of drug-resistant tuberculosis among children and adults are expected to boost the market growth. 

KEY MARKET PLAYERS

The top companies dominating in the APAC BCG Vaccine Market profiled in the report are Merck & Co., Inc., Sanofi Pasteur, China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation), InterVax Ltd, Statens Serum Institute, Japan BCG Laboratory, Serum Institute of India Pvt. Ltd.,

1. Introduction                                

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods   

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Demographics                          

                              5.1.1 Introduction           

                              5.1.2 Pediatrics (0-18 years)        

                              5.1.3 Adults (19-35 years)            

                              5.1.4 Y-o-Y Growth Analysis, By Demographics   

                              5.1.5 Market Attractiveness Analysis, By Demographics

                              5.1.6 Market Share Analysis, By Demographics   

               5.2 Product Type                            

                              5.2.1 BCG Vaccine Market           

                              5.2.2 Immune BCG         

                              5.2.3 Therapy BCG          

                              5.2.4 Y-o-Y Growth Analysis, By Product Type     

                              5.2.5 Market Attractiveness Analysis, By Product Type

                              5.2.6 Market Share Analysis, By Product Type     

               5.3 End User                     

                              5.3.1 Pediatrics 

                              5.3.2 Adults       

                              5.3.4 Y-o-Y Growth Analysis, By End User             

                              5.3.5 Market Attractiveness Analysis, By End User  

                              5.3.6 Market Share Analysis, By End User             

               5.4 Applications               

                              5.4.1 Home        

                              5.4.2 Commercial            

                              5.4.4 Y-o-Y Growth Analysis, By Applications       

                              5.4.5 Market Attractiveness Analysis, By Applications

                              5.4.6 Market Share Analysis, By Applications       

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Demographics

                                             6.1.3.3 By Product Type

                                             6.1.3.4 By End User

                                             6.1.3.5 By Applications

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Demographics

                                             6.1.4.3 By Product Type

                                             6.1.4.4 By End User

                                             6.1.4.5 By Applications

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Demographics

                                             6.1.5.3 By Product Type

                                             6.1.5.4 By End User

                                             6.1.5.5 By Applications

               6.2 China                           

               6.3 India                            

               6.4 Japan                           

               6.5 South Korea               

               6.6 Australia                     

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Merck & Co., Inc.                    

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Sanofi Pasteur                          

               8.3 Japan BCG Laboratory                          

               8.4 China National Biotec Group (a subsidiary of China National Pharmaceutical Group Corporation)                     

               8.5 Serum Institute of India Pvt. Ltd.                      

               8.6 InterVax Ltd.                            

               8.7 GreenSignal Bio Pharma Limited (GSBPL)                      

               8.8 Statens Serum Institute                        

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  1. Asia Pacific BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )
  2. Asia Pacific Pediatrics (0-18 years) Market By Region, From 2022 - 2027 ( USD Billion )
  3. Asia Pacific Adults (19-35 years) Market By Region, From 2022 - 2027 ( USD Billion )
  4. Japan BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )
  5. China BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )
  6. India BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )
  7. Australia BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )
  8. South Korea BCG Vaccine Market By Demographics, From 2022 - 2027 ( USD Billion )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample